Orally administered liposomal formulations for colon targeted drug delivery.

about

RNA interference-based nanosystems for inflammatory bowel disease therapy Elastic liposomes as novel carriers: recent advances in drug delivery.Ultra-small solid archaeolipid nanoparticles for active targeting to macrophages of the inflamed mucosa.

P2860

Q28071518-6A7E2AD7-EFA6-4F0B-A4A8-D8DF7173E762 Q38648991-84FE1260-FCED-4D26-861E-286758484743 Q51032601-3D1DB3AA-57BD-4DF5-9CBA-1521CF6DAC9C

P2860

Orally administered liposomal formulations for colon targeted drug delivery.

Item

http://www.wikidata.org/entity/Q40475538

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Orally administered liposomal formulations for colon targeted drug delivery.

@en

type

Item

label

Orally administered liposomal formulations for colon targeted drug delivery.

@en

prefLabel

Orally administered liposomal formulations for colon targeted drug delivery.

@en

P1476

Orally administered liposomal formulations for colon targeted drug delivery.

@en

P2093

Susan Hua

http://www.w3.org/2001/XMLSchema#string

P2860

Enhanced transferrin receptor expression by proinflammatory cytokines in enterocytes as a means for local delivery of drugs to inflamed gut mucosa

Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexes.

Biophysical studies on chitosan-coated liposomes.

Transferrin As A targeting ligand for liposomes and anticancer drugs.

Evaluation of liposomes coated with a pH responsive polymer.

Antibody diffusion in human cervical mucus.

Immunoliposomes: a promising approach to targeting cancer therapy.

Beta 2-integrin/intercellular adhesion molecule (ICAM) expression in the normal human intestine.

PEG-immunoliposome.

Biodistribution and endocytosis of ICAM-1-targeting antibodies versus nanocarriers in the gastrointestinal tract in mice.

P304

138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3389/FPHAR.2014.00138

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263396591

http://www.w3.org/2001/XMLSchema#string

P698

24959147

http://www.w3.org/2001/XMLSchema#string

P921

drug delivery

P932

4050429

http://www.w3.org/2001/XMLSchema#string

Orally administered liposomal formulations for colon targeted drug delivery.

about

P2860

P2860

Orally administered liposomal formulations for colon targeted drug delivery.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921

P932